Valuation Abbott India Limited

Equities

Market Closed - Bombay S.E. Other stock markets 03:30:48 20/04/2026 pm IST			5-day change	1st Jan Change
25,578.90 ^INR	-0.85%		-0.57%	-12.01%

27/02	Abbott India partners with Novo Nordisk India to launch Extensior	RE
27/02	Abbott Partners with Novo Nordisk India to Launch Extensior, Broadening Access to Semaglutide for Advanced Diabetes Management	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	3,18,498	3,76,101	4,69,324	5,72,584	6,53,005	5,48,171	-	-
Change	-	18.09%	24.79%	22%	14.05%	-16.05%	-	-
Enterprise Value (EV) ¹	2,94,408	3,48,609	4,49,953	5,51,239	6,36,726	5,30,586	5,25,621	5,21,161
Change	-	18.41%	29.07%	22.51%	15.51%	-16.67%	-0.94%	-0.85%
P/E ratio	46.1x	47.1x	49.4x	47.7x	46.2x	35x	31.7x	28.5x
PBR	12.2x	13.3x	14.7x	15.5x	15.4x	11.7x	10.6x	9.48x
PEG	-	3x	2.6x	1.8x	2.6x	3.2x	3.1x	2.5x
Capitalization / Revenue	7.39x	7.65x	8.77x	9.79x	10.2x	7.92x	7.33x	6.66x
EV / Revenue	6.83x	7.09x	8.41x	9.42x	9.93x	7.67x	7.02x	6.33x
EV / EBITDA	32x	32x	37.3x	37.9x	37.6x	28x	24.7x	21.9x
EV / EBIT	34.1x	34.1x	39.6x	39.9x	39.2x	29.5x	26.7x	23.5x
EV / FCF	41.9x	38.6x	52.4x	47.3x	66.4x	40.6x	35.3x	31x
FCF Yield	2.39%	2.59%	1.91%	2.11%	1.51%	2.46%	2.83%	3.23%
Dividend per Share ²	120	145	180	410	475	505.6	572.6	652.8
Rate of return	0.8%	0.82%	0.81%	1.52%	1.55%	1.96%	2.22%	2.53%
EPS ²	325	375.9	446.8	565.3	665.6	737.6	813.8	906
Distribution rate	36.9%	38.6%	40.3%	72.5%	71.4%	68.5%	70.4%	72%
Net sales ¹	43,100	49,193	53,487	58,489	64,092	69,176	74,835	82,283
EBITDA ¹	9,215	10,877	12,056	14,531	16,946	18,970	21,247	23,809
EBIT ¹	8,633	10,216	11,357	13,819	16,228	18,008	19,676	22,220
Net income ¹	6,907	7,987	9,494	12,012	14,144	15,658	17,294	19,253
Net Debt ¹	-24,090	-27,492	-19,371	-21,345	-16,279	-17,585	-22,551	-27,010
Reference price ²	14,988.65	17,699.45	22,086.55	26,946.00	30,730.65	25,797.15	25,797.15	25,797.15
Nbr of stocks (in thousands)	21,249	21,249	21,249	21,249	21,249	21,249	-	-
Announcement Date	18/05/21	17/05/22	19/05/23	09/05/24	15/05/25	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT INDIA LIMITED	34.97x	7.67x	27.97x	1.96%	592.41Cr
ELI LILLY AND COMPANY	27.27x	10.33x	20.7x	0.73%	83TCr
JOHNSON & JOHNSON	25.1x	5.77x	15.66x	2.28%	56TCr
ABBVIE INC.	23.45x	6.27x	12.73x	3.32%	37TCr
ROCHE HOLDING AG	17.18x	4.23x	10.41x	3.13%	33TCr
ASTRAZENECA PLC	25.85x	5.33x	15.06x	1.62%	32TCr
MERCK & CO., INC.	28.63x	4.9x	15.22x	2.84%	29TCr
NOVARTIS AG	21.14x	5.67x	13.72x	2.9%	29TCr
AMGEN INC.	23.44x	6.15x	10.83x	2.83%	19TCr
NOVO NORDISK A/S	12.34x	4.43x	9.26x	4.19%	18TCr
Average	23.94x	6.07x	15.16x	2.58%	33.73TCr
Weighted average by Cap.	23.95x	6.62x	15.21x	2.27%